Kathryn Colborn
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 9 | 2022 | 842 | 2.960 |
Why?
| Postoperative Complications | 27 | 2023 | 2301 | 2.410 |
Why?
| Quality Improvement | 14 | 2023 | 1004 | 1.460 |
Why?
| Urinary Tract Infections | 3 | 2022 | 143 | 1.430 |
Why?
| Surgical Procedures, Operative | 5 | 2023 | 227 | 1.370 |
Why?
| Machine Learning | 6 | 2022 | 345 | 1.240 |
Why?
| Malaria | 4 | 2023 | 58 | 1.200 |
Why?
| Pancreatic Neoplasms | 7 | 2023 | 803 | 0.910 |
Why?
| Postoperative Hemorrhage | 2 | 2023 | 89 | 0.880 |
Why?
| Models, Statistical | 4 | 2020 | 651 | 0.870 |
Why?
| Malaria, Falciparum | 2 | 2018 | 31 | 0.840 |
Why?
| Artificial Intelligence | 1 | 2023 | 146 | 0.820 |
Why?
| Sepsis | 5 | 2022 | 546 | 0.810 |
Why?
| Surgical Wound Infection | 4 | 2022 | 251 | 0.810 |
Why?
| Plasmodium vivax | 2 | 2018 | 6 | 0.760 |
Why?
| Malaria, Vivax | 2 | 2018 | 6 | 0.760 |
Why?
| Retrospective Studies | 39 | 2023 | 13433 | 0.750 |
Why?
| Pain | 2 | 2023 | 746 | 0.740 |
Why?
| Humans | 107 | 2024 | 122796 | 0.730 |
Why?
| Inpatients | 4 | 2023 | 402 | 0.680 |
Why?
| Poisson Distribution | 1 | 2018 | 73 | 0.630 |
Why?
| Plasmodium falciparum | 1 | 2018 | 34 | 0.630 |
Why?
| Health Plan Implementation | 1 | 2019 | 132 | 0.620 |
Why?
| Risk Assessment | 15 | 2023 | 3213 | 0.600 |
Why?
| Databases, Factual | 12 | 2023 | 1287 | 0.600 |
Why?
| Hospitalization | 6 | 2021 | 1914 | 0.590 |
Why?
| Mosquito Control | 2 | 2023 | 26 | 0.580 |
Why?
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 228 | 0.540 |
Why?
| Mosquito Nets | 1 | 2015 | 2 | 0.540 |
Why?
| Palliative Care | 6 | 2023 | 632 | 0.540 |
Why?
| Anopheles | 1 | 2015 | 16 | 0.530 |
Why?
| Shock, Septic | 3 | 2022 | 213 | 0.500 |
Why?
| Surgeons | 3 | 2023 | 245 | 0.500 |
Why?
| Drug Prescriptions | 3 | 2021 | 271 | 0.490 |
Why?
| Breast Neoplasms | 5 | 2023 | 1994 | 0.470 |
Why?
| Middle Aged | 29 | 2023 | 28563 | 0.460 |
Why?
| Female | 43 | 2023 | 63629 | 0.440 |
Why?
| Risk Factors | 21 | 2023 | 9381 | 0.440 |
Why?
| Ambulatory Surgical Procedures | 2 | 2023 | 53 | 0.440 |
Why?
| Patient Discharge | 2 | 2020 | 842 | 0.440 |
Why?
| Thoracic Surgery | 2 | 2023 | 123 | 0.420 |
Why?
| Hospital Mortality | 1 | 2016 | 901 | 0.420 |
Why?
| Adult | 28 | 2023 | 32385 | 0.410 |
Why?
| Hospice and Palliative Care Nursing | 2 | 2023 | 66 | 0.410 |
Why?
| Male | 38 | 2023 | 59639 | 0.410 |
Why?
| Primary Health Care | 2 | 2019 | 1625 | 0.400 |
Why?
| Algorithms | 4 | 2019 | 1593 | 0.400 |
Why?
| Quality of Life | 8 | 2024 | 2457 | 0.400 |
Why?
| Aged | 21 | 2023 | 20495 | 0.390 |
Why?
| Opioid-Related Disorders | 1 | 2018 | 412 | 0.390 |
Why?
| Neoadjuvant Therapy | 6 | 2023 | 348 | 0.380 |
Why?
| Influenza, Human | 3 | 2021 | 566 | 0.370 |
Why?
| Patient Reported Outcome Measures | 5 | 2024 | 258 | 0.370 |
Why?
| Extracorporeal Membrane Oxygenation | 2 | 2023 | 249 | 0.360 |
Why?
| Emergency Treatment | 2 | 2021 | 117 | 0.350 |
Why?
| Child, Preschool | 13 | 2023 | 9755 | 0.350 |
Why?
| Research Design | 3 | 2022 | 1002 | 0.310 |
Why?
| Hospitals | 3 | 2022 | 633 | 0.310 |
Why?
| Osteoarthritis, Knee | 2 | 2021 | 225 | 0.310 |
Why?
| Autism Spectrum Disorder | 2 | 2023 | 350 | 0.300 |
Why?
| Logistic Models | 5 | 2023 | 1995 | 0.300 |
Why?
| Incidence | 6 | 2020 | 2527 | 0.300 |
Why?
| Arthroplasty, Replacement, Knee | 2 | 2021 | 249 | 0.300 |
Why?
| Chagas Disease | 2 | 2018 | 35 | 0.300 |
Why?
| Rectal Neoplasms | 2 | 2019 | 122 | 0.300 |
Why?
| Aged, 80 and over | 9 | 2023 | 6845 | 0.290 |
Why?
| Mass Drug Administration | 3 | 2023 | 8 | 0.290 |
Why?
| Cohort Studies | 10 | 2023 | 5294 | 0.290 |
Why?
| Adenocarcinoma | 2 | 2023 | 837 | 0.280 |
Why?
| Colorado | 7 | 2021 | 4325 | 0.280 |
Why?
| Asthma | 1 | 2019 | 2130 | 0.270 |
Why?
| United States | 15 | 2023 | 13272 | 0.250 |
Why?
| Heart Failure | 4 | 2018 | 2114 | 0.250 |
Why?
| Emergency Service, Hospital | 3 | 2020 | 1922 | 0.250 |
Why?
| Analgesics, Opioid | 3 | 2021 | 785 | 0.240 |
Why?
| Young Adult | 11 | 2020 | 11094 | 0.230 |
Why?
| Metastasectomy | 1 | 2023 | 13 | 0.230 |
Why?
| Hernia, Hiatal | 1 | 2023 | 34 | 0.230 |
Why?
| Specialties, Surgical | 2 | 2021 | 76 | 0.230 |
Why?
| Predictive Value of Tests | 4 | 2022 | 1947 | 0.230 |
Why?
| Endarterectomy, Carotid | 1 | 2023 | 47 | 0.230 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2023 | 32 | 0.220 |
Why?
| Insecticides | 1 | 2023 | 37 | 0.220 |
Why?
| Thoracic Surgical Procedures | 1 | 2023 | 65 | 0.220 |
Why?
| Practice Patterns, Physicians' | 3 | 2021 | 1267 | 0.220 |
Why?
| Europe | 1 | 2023 | 369 | 0.220 |
Why?
| Microcephaly | 1 | 2023 | 56 | 0.220 |
Why?
| MEF2 Transcription Factors | 1 | 2022 | 60 | 0.220 |
Why?
| Carotid Stenosis | 1 | 2023 | 80 | 0.220 |
Why?
| Gastrointestinal Neoplasms | 1 | 2023 | 62 | 0.220 |
Why?
| Multivariate Analysis | 2 | 2023 | 1531 | 0.220 |
Why?
| Ischemic Attack, Transient | 1 | 2023 | 64 | 0.220 |
Why?
| Risk Adjustment | 1 | 2023 | 83 | 0.220 |
Why?
| Polypharmacy | 1 | 2023 | 78 | 0.220 |
Why?
| Pain, Postoperative | 2 | 2021 | 214 | 0.220 |
Why?
| Sentinel Lymph Node | 1 | 2022 | 40 | 0.220 |
Why?
| Adolescent | 13 | 2023 | 18948 | 0.210 |
Why?
| Medication Therapy Management | 1 | 2023 | 73 | 0.210 |
Why?
| Robotic Surgical Procedures | 1 | 2024 | 94 | 0.210 |
Why?
| Drug Hypersensitivity | 1 | 2023 | 82 | 0.210 |
Why?
| Galectins | 1 | 2022 | 22 | 0.210 |
Why?
| Delirium | 1 | 2023 | 72 | 0.210 |
Why?
| Chemoradiotherapy, Adjuvant | 2 | 2019 | 42 | 0.210 |
Why?
| Neuroendocrine Tumors | 1 | 2023 | 91 | 0.210 |
Why?
| Chemotherapy, Adjuvant | 4 | 2023 | 369 | 0.210 |
Why?
| Ivermectin | 1 | 2021 | 10 | 0.200 |
Why?
| Mozambique | 2 | 2018 | 5 | 0.200 |
Why?
| Preoperative Care | 2 | 2021 | 342 | 0.200 |
Why?
| Mastectomy, Segmental | 1 | 2021 | 90 | 0.200 |
Why?
| Knee Joint | 2 | 2021 | 366 | 0.200 |
Why?
| Prognosis | 7 | 2023 | 3563 | 0.200 |
Why?
| Dysbiosis | 1 | 2022 | 148 | 0.190 |
Why?
| Oxycodone | 1 | 2021 | 45 | 0.190 |
Why?
| New Guinea | 2 | 2018 | 4 | 0.190 |
Why?
| Gastric Bypass | 1 | 2022 | 93 | 0.190 |
Why?
| Intensive Care Units | 2 | 2022 | 664 | 0.190 |
Why?
| Program Evaluation | 3 | 2021 | 880 | 0.190 |
Why?
| Surgery Department, Hospital | 1 | 2020 | 22 | 0.190 |
Why?
| Terminal Care | 1 | 2023 | 186 | 0.190 |
Why?
| Arthroplasty | 1 | 2020 | 53 | 0.180 |
Why?
| Anti-Anxiety Agents | 1 | 2010 | 41 | 0.180 |
Why?
| Faculty | 1 | 2021 | 133 | 0.180 |
Why?
| Artemisinins | 1 | 2019 | 2 | 0.180 |
Why?
| Antimalarials | 1 | 2019 | 24 | 0.180 |
Why?
| Hypersensitivity | 1 | 2023 | 259 | 0.180 |
Why?
| Infant | 8 | 2023 | 8523 | 0.180 |
Why?
| Prisons | 1 | 2010 | 57 | 0.180 |
Why?
| Zebrafish Proteins | 1 | 2022 | 284 | 0.180 |
Why?
| Venous Thromboembolism | 1 | 2023 | 239 | 0.170 |
Why?
| General Surgery | 1 | 2021 | 146 | 0.170 |
Why?
| Radiotherapy, Intensity-Modulated | 2 | 2019 | 128 | 0.170 |
Why?
| Waiting Lists | 2 | 2021 | 229 | 0.170 |
Why?
| Organ Transplantation | 1 | 2021 | 165 | 0.170 |
Why?
| Latent Tuberculosis | 1 | 2010 | 63 | 0.170 |
Why?
| Rural Population | 2 | 2020 | 482 | 0.170 |
Why?
| Induction Chemotherapy | 1 | 2019 | 59 | 0.170 |
Why?
| Obesity, Morbid | 1 | 2022 | 204 | 0.170 |
Why?
| Laparoscopy | 1 | 2023 | 426 | 0.170 |
Why?
| Anti-Infective Agents | 1 | 2022 | 248 | 0.170 |
Why?
| Outpatients | 1 | 2022 | 336 | 0.170 |
Why?
| Treatment Outcome | 9 | 2023 | 9692 | 0.170 |
Why?
| Aftercare | 1 | 2020 | 203 | 0.170 |
Why?
| Burns | 1 | 2022 | 256 | 0.170 |
Why?
| Condoms, Female | 1 | 2008 | 6 | 0.170 |
Why?
| Cognition | 2 | 2023 | 1066 | 0.170 |
Why?
| Quinolines | 1 | 2019 | 127 | 0.170 |
Why?
| Cardiac Surgical Procedures | 1 | 2023 | 477 | 0.160 |
Why?
| Soft Tissue Infections | 1 | 2008 | 29 | 0.160 |
Why?
| Social Marketing | 1 | 2008 | 15 | 0.160 |
Why?
| Datasets as Topic | 1 | 2019 | 110 | 0.160 |
Why?
| Reproductive Medicine | 1 | 2008 | 14 | 0.160 |
Why?
| Triage | 1 | 2021 | 215 | 0.160 |
Why?
| Herpesvirus 4, Human | 1 | 2019 | 127 | 0.160 |
Why?
| Community Participation | 1 | 2019 | 125 | 0.160 |
Why?
| Ventricular Function | 1 | 2018 | 61 | 0.160 |
Why?
| Developed Countries | 1 | 2018 | 37 | 0.160 |
Why?
| Education, Medical, Undergraduate | 1 | 2021 | 204 | 0.160 |
Why?
| Hospitals, University | 1 | 2018 | 183 | 0.160 |
Why?
| Autistic Disorder | 1 | 2020 | 176 | 0.160 |
Why?
| Zebrafish | 1 | 2022 | 477 | 0.160 |
Why?
| Epstein-Barr Virus Infections | 1 | 2019 | 73 | 0.160 |
Why?
| Computers, Handheld | 1 | 2018 | 26 | 0.160 |
Why?
| ROC Curve | 1 | 2019 | 494 | 0.160 |
Why?
| Population Groups | 1 | 2018 | 57 | 0.160 |
Why?
| Patient Admission | 1 | 2019 | 195 | 0.160 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 410 | 0.160 |
Why?
| Climate | 1 | 2018 | 94 | 0.160 |
Why?
| Immunoglobulin A | 1 | 2019 | 179 | 0.160 |
Why?
| Substance Abuse, Intravenous | 1 | 2008 | 77 | 0.160 |
Why?
| Sentinel Surveillance | 1 | 2017 | 39 | 0.160 |
Why?
| Occupational Health | 1 | 2010 | 175 | 0.160 |
Why?
| Geography | 1 | 2018 | 199 | 0.150 |
Why?
| Sentinel Lymph Node Biopsy | 3 | 2023 | 118 | 0.150 |
Why?
| Safety-net Providers | 1 | 2019 | 106 | 0.150 |
Why?
| Recovery of Function | 1 | 2021 | 610 | 0.150 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 302 | 0.150 |
Why?
| Condoms | 1 | 2008 | 123 | 0.150 |
Why?
| Defibrillators, Implantable | 1 | 2022 | 397 | 0.150 |
Why?
| Patient Compliance | 1 | 2021 | 561 | 0.150 |
Why?
| Epidemics | 1 | 2018 | 76 | 0.150 |
Why?
| Child | 10 | 2023 | 19561 | 0.150 |
Why?
| Lymph Node Excision | 3 | 2023 | 161 | 0.150 |
Why?
| Anxiety Disorders | 1 | 2010 | 326 | 0.150 |
Why?
| Gastroenteritis | 1 | 2017 | 65 | 0.150 |
Why?
| Occupational Exposure | 1 | 2010 | 298 | 0.150 |
Why?
| Cell Phone | 1 | 2017 | 84 | 0.140 |
Why?
| Membrane Glycoproteins | 1 | 2019 | 462 | 0.140 |
Why?
| Students, Medical | 1 | 2021 | 328 | 0.140 |
Why?
| Influenza Vaccines | 1 | 2021 | 504 | 0.140 |
Why?
| Radiotherapy, Conformal | 1 | 2016 | 67 | 0.140 |
Why?
| Nurse Practitioners | 1 | 2018 | 112 | 0.140 |
Why?
| Alcoholism | 1 | 2023 | 725 | 0.140 |
Why?
| Fever | 1 | 2017 | 289 | 0.140 |
Why?
| Mass Screening | 2 | 2020 | 1095 | 0.140 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2017 | 116 | 0.140 |
Why?
| Patient Readmission | 2 | 2020 | 691 | 0.140 |
Why?
| Forecasting | 1 | 2018 | 372 | 0.140 |
Why?
| Cannabidiol | 1 | 2016 | 59 | 0.140 |
Why?
| Healthcare Disparities | 2 | 2018 | 494 | 0.140 |
Why?
| Morbidity | 3 | 2022 | 309 | 0.140 |
Why?
| Melanoma | 1 | 2022 | 709 | 0.140 |
Why?
| Models, Organizational | 1 | 2016 | 144 | 0.130 |
Why?
| Antibodies, Viral | 1 | 2019 | 551 | 0.130 |
Why?
| Humidity | 1 | 2015 | 45 | 0.130 |
Why?
| Mobile Applications | 1 | 2017 | 155 | 0.130 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1402 | 0.130 |
Why?
| Advance Care Planning | 1 | 2018 | 191 | 0.130 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2023 | 770 | 0.130 |
Why?
| Atrial Fibrillation | 1 | 2020 | 392 | 0.130 |
Why?
| Diarrhea | 3 | 2023 | 181 | 0.130 |
Why?
| Skin Neoplasms | 1 | 2022 | 841 | 0.130 |
Why?
| Anticonvulsants | 1 | 2016 | 189 | 0.130 |
Why?
| Massage | 2 | 2010 | 45 | 0.130 |
Why?
| Chronic Pain | 1 | 2018 | 214 | 0.120 |
Why?
| Stroke | 1 | 2023 | 1090 | 0.120 |
Why?
| Environmental Exposure | 1 | 2018 | 427 | 0.120 |
Why?
| Parasitemia | 1 | 2013 | 9 | 0.120 |
Why?
| Sensitivity and Specificity | 1 | 2018 | 1855 | 0.120 |
Why?
| Family Practice | 1 | 2018 | 485 | 0.120 |
Why?
| Models, Biological | 1 | 2021 | 1756 | 0.120 |
Why?
| Heart Defects, Congenital | 1 | 2020 | 721 | 0.120 |
Why?
| Indians, North American | 1 | 2009 | 597 | 0.120 |
Why?
| Software | 1 | 2018 | 631 | 0.110 |
Why?
| Emergency Medical Services | 1 | 2021 | 635 | 0.110 |
Why?
| Research | 1 | 2016 | 432 | 0.110 |
Why?
| Prospective Studies | 5 | 2024 | 6704 | 0.110 |
Why?
| Medicaid | 1 | 2017 | 416 | 0.110 |
Why?
| Myocardial Infarction | 1 | 2020 | 1134 | 0.110 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2023 | 1260 | 0.110 |
Why?
| Epilepsy | 1 | 2016 | 291 | 0.110 |
Why?
| Multicenter Studies as Topic | 2 | 2023 | 247 | 0.110 |
Why?
| Heart-Assist Devices | 1 | 2018 | 487 | 0.110 |
Why?
| Temperature | 1 | 2015 | 631 | 0.110 |
Why?
| Axilla | 2 | 2023 | 58 | 0.110 |
Why?
| Feedback | 2 | 2023 | 155 | 0.100 |
Why?
| Mastectomy | 2 | 2023 | 125 | 0.100 |
Why?
| Pain Management | 2 | 2010 | 306 | 0.100 |
Why?
| Prevalence | 3 | 2023 | 2442 | 0.100 |
Why?
| Patients | 2 | 2023 | 176 | 0.100 |
Why?
| Disease Progression | 1 | 2019 | 2546 | 0.100 |
Why?
| Uganda | 2 | 2023 | 76 | 0.100 |
Why?
| Age Factors | 4 | 2021 | 3114 | 0.100 |
Why?
| Lymphatic Metastasis | 2 | 2023 | 310 | 0.100 |
Why?
| Heart Transplantation | 1 | 2017 | 674 | 0.100 |
Why?
| Internship and Residency | 1 | 2021 | 1065 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2019 | 2784 | 0.090 |
Why?
| Lung Neoplasms | 1 | 2023 | 2216 | 0.090 |
Why?
| Antineoplastic Agents | 1 | 2021 | 1990 | 0.090 |
Why?
| Postoperative Period | 2 | 2021 | 317 | 0.090 |
Why?
| Laboratories | 2 | 2021 | 106 | 0.090 |
Why?
| Anti-HIV Agents | 1 | 2016 | 685 | 0.090 |
Why?
| Guatemala | 2 | 2023 | 311 | 0.090 |
Why?
| Pandemics | 3 | 2023 | 1401 | 0.090 |
Why?
| Feeding Behavior | 1 | 2015 | 627 | 0.090 |
Why?
| Lymph Nodes | 2 | 2023 | 466 | 0.090 |
Why?
| Delivery of Health Care | 1 | 2016 | 915 | 0.090 |
Why?
| Seasons | 2 | 2020 | 468 | 0.080 |
Why?
| Surveys and Questionnaires | 4 | 2023 | 4882 | 0.080 |
Why?
| Survival Rate | 2 | 2023 | 1810 | 0.080 |
Why?
| Proportional Hazards Models | 2 | 2023 | 1184 | 0.080 |
Why?
| Referral and Consultation | 2 | 2023 | 669 | 0.080 |
Why?
| Immunization Programs | 1 | 2009 | 210 | 0.070 |
Why?
| Comorbidity | 2 | 2022 | 1600 | 0.070 |
Why?
| Length of Stay | 2 | 2023 | 1077 | 0.070 |
Why?
| Follow-Up Studies | 3 | 2021 | 4768 | 0.070 |
Why?
| Urban Population | 2 | 2020 | 425 | 0.070 |
Why?
| School Health Services | 1 | 2009 | 207 | 0.070 |
Why?
| Affect | 1 | 2008 | 254 | 0.070 |
Why?
| Pilot Projects | 2 | 2023 | 1477 | 0.070 |
Why?
| Insurance Coverage | 2 | 2017 | 218 | 0.070 |
Why?
| Patient Satisfaction | 2 | 2021 | 632 | 0.070 |
Why?
| Cross-Sectional Studies | 3 | 2023 | 4734 | 0.060 |
Why?
| Body Mass Index | 2 | 2023 | 2144 | 0.060 |
Why?
| Socioeconomic Factors | 2 | 2020 | 1158 | 0.060 |
Why?
| Pneumonia | 2 | 2020 | 605 | 0.060 |
Why?
| Cytokines | 2 | 2023 | 1928 | 0.060 |
Why?
| Acute Disease | 2 | 2017 | 984 | 0.060 |
Why?
| Health Care Surveys | 2 | 2010 | 564 | 0.060 |
Why?
| Community Health Workers | 1 | 2023 | 49 | 0.060 |
Why?
| Herniorrhaphy | 1 | 2023 | 53 | 0.060 |
Why?
| Multilocus Sequence Typing | 1 | 2022 | 12 | 0.060 |
Why?
| Health Facilities | 1 | 2023 | 78 | 0.060 |
Why?
| Growth Disorders | 1 | 2023 | 82 | 0.060 |
Why?
| Death | 1 | 2023 | 108 | 0.060 |
Why?
| Biological Variation, Population | 1 | 2022 | 24 | 0.060 |
Why?
| Anti-Bacterial Agents | 2 | 2023 | 1562 | 0.060 |
Why?
| Body Surface Area | 1 | 2022 | 28 | 0.060 |
Why?
| Vomiting | 1 | 2023 | 126 | 0.060 |
Why?
| Burn Units | 1 | 2022 | 26 | 0.060 |
Why?
| Papua New Guinea | 1 | 2012 | 8 | 0.050 |
Why?
| Breast | 1 | 2023 | 141 | 0.050 |
Why?
| Cough | 1 | 2023 | 104 | 0.050 |
Why?
| Patient Acuity | 1 | 2022 | 37 | 0.050 |
Why?
| HIV Infections | 1 | 2016 | 2532 | 0.050 |
Why?
| Carotid Arteries | 1 | 2023 | 189 | 0.050 |
Why?
| Neutrophil Infiltration | 1 | 2022 | 100 | 0.050 |
Why?
| Neurosurgical Procedures | 1 | 2023 | 165 | 0.050 |
Why?
| Disease-Free Survival | 1 | 2023 | 661 | 0.050 |
Why?
| Focus Groups | 1 | 2023 | 391 | 0.050 |
Why?
| Inappropriate Prescribing | 1 | 2022 | 51 | 0.050 |
Why?
| Gastrectomy | 1 | 2022 | 85 | 0.050 |
Why?
| Pancreatectomy | 1 | 2023 | 191 | 0.050 |
Why?
| Demography | 1 | 2022 | 290 | 0.050 |
Why?
| Educational Status | 1 | 2023 | 448 | 0.050 |
Why?
| Sample Size | 1 | 2021 | 135 | 0.050 |
Why?
| Habits | 1 | 2020 | 39 | 0.050 |
Why?
| Ligands | 1 | 2023 | 582 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2023 | 321 | 0.050 |
Why?
| Preoperative Period | 1 | 2021 | 112 | 0.050 |
Why?
| Chemoradiotherapy | 1 | 2022 | 201 | 0.050 |
Why?
| Censuses | 1 | 2020 | 22 | 0.050 |
Why?
| Research Personnel | 1 | 2022 | 158 | 0.050 |
Why?
| Fear | 1 | 2023 | 313 | 0.050 |
Why?
| Lung | 2 | 2024 | 3830 | 0.050 |
Why?
| South Africa | 1 | 2021 | 165 | 0.050 |
Why?
| Reoperation | 1 | 2023 | 570 | 0.050 |
Why?
| Animals | 3 | 2022 | 34133 | 0.050 |
Why?
| Schools, Medical | 1 | 2021 | 152 | 0.050 |
Why?
| Policy | 1 | 2021 | 134 | 0.050 |
Why?
| Combined Modality Therapy | 1 | 2023 | 1174 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 159 | 0.050 |
Why?
| Blood Proteins | 1 | 2022 | 249 | 0.040 |
Why?
| Cluster Analysis | 1 | 2021 | 493 | 0.040 |
Why?
| Elective Surgical Procedures | 1 | 2021 | 165 | 0.040 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 39 | 0.040 |
Why?
| Early Diagnosis | 1 | 2020 | 242 | 0.040 |
Why?
| Mentors | 1 | 2021 | 170 | 0.040 |
Why?
| Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 8 | 0.040 |
Why?
| Urination Disorders | 1 | 2019 | 15 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2023 | 1234 | 0.040 |
Why?
| Leucovorin | 1 | 2019 | 45 | 0.040 |
Why?
| Organoplatinum Compounds | 1 | 2019 | 41 | 0.040 |
Why?
| Societies, Medical | 1 | 2023 | 741 | 0.040 |
Why?
| Program Development | 1 | 2021 | 372 | 0.040 |
Why?
| Risk | 1 | 2022 | 890 | 0.040 |
Why?
| Kenya | 1 | 2019 | 103 | 0.040 |
Why?
| Chi-Square Distribution | 1 | 2010 | 551 | 0.040 |
Why?
| Overweight | 1 | 2023 | 516 | 0.040 |
Why?
| Survivors | 1 | 2022 | 440 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2022 | 515 | 0.040 |
Why?
| Time Factors | 2 | 2021 | 6682 | 0.040 |
Why?
| Drug Combinations | 1 | 2019 | 292 | 0.040 |
Why?
| Cardiovascular Nursing | 1 | 2018 | 3 | 0.040 |
Why?
| Bayes Theorem | 1 | 2020 | 363 | 0.040 |
Why?
| Washington | 1 | 2008 | 139 | 0.040 |
Why?
| Colombia | 1 | 2018 | 43 | 0.040 |
Why?
| Fluorouracil | 1 | 2019 | 160 | 0.040 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 147 | 0.040 |
Why?
| Guidelines as Topic | 1 | 2010 | 273 | 0.040 |
Why?
| Rectum | 1 | 2019 | 158 | 0.040 |
Why?
| Range of Motion, Articular | 1 | 2020 | 385 | 0.040 |
Why?
| Hospitals, Veterans | 1 | 2009 | 260 | 0.040 |
Why?
| Coinfection | 1 | 2019 | 122 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2023 | 903 | 0.040 |
Why?
| Patient-Centered Care | 1 | 2023 | 513 | 0.040 |
Why?
| Mental Health | 1 | 2023 | 571 | 0.040 |
Why?
| Mortality | 1 | 2019 | 317 | 0.040 |
Why?
| Infant, Newborn | 2 | 2019 | 5430 | 0.040 |
Why?
| Weight Loss | 1 | 2022 | 663 | 0.040 |
Why?
| Prisoners | 1 | 2008 | 93 | 0.040 |
Why?
| Viral Load | 1 | 2019 | 423 | 0.040 |
Why?
| Proctitis | 1 | 2016 | 4 | 0.040 |
Why?
| Odds Ratio | 1 | 2010 | 1043 | 0.040 |
Why?
| Urogenital System | 1 | 2016 | 17 | 0.040 |
Why?
| Prosthesis Design | 1 | 2018 | 293 | 0.040 |
Why?
| Latin America | 1 | 2016 | 77 | 0.040 |
Why?
| Models, Theoretical | 1 | 2021 | 574 | 0.040 |
Why?
| Anxiety | 1 | 2023 | 888 | 0.040 |
Why?
| Radiotherapy Dosage | 1 | 2016 | 244 | 0.040 |
Why?
| Population Surveillance | 1 | 2019 | 439 | 0.030 |
Why?
| Medically Uninsured | 1 | 2017 | 133 | 0.030 |
Why?
| Health Status | 1 | 2021 | 758 | 0.030 |
Why?
| Guideline Adherence | 1 | 2010 | 560 | 0.030 |
Why?
| Radiation Injuries | 1 | 2016 | 137 | 0.030 |
Why?
| Echocardiography | 1 | 2018 | 591 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2008 | 218 | 0.030 |
Why?
| Self Care | 1 | 2018 | 360 | 0.030 |
Why?
| Plant Extracts | 1 | 2016 | 169 | 0.030 |
Why?
| Public Health | 1 | 2019 | 480 | 0.030 |
Why?
| Curriculum | 1 | 2021 | 925 | 0.030 |
Why?
| Insurance, Health | 1 | 2017 | 259 | 0.030 |
Why?
| Hemorrhage | 1 | 2019 | 663 | 0.030 |
Why?
| Electrocardiography | 1 | 2018 | 620 | 0.030 |
Why?
| Transcription Factors | 1 | 2022 | 1616 | 0.030 |
Why?
| Neoplasms | 1 | 2008 | 2235 | 0.030 |
Why?
| Administration, Oral | 1 | 2016 | 786 | 0.030 |
Why?
| Linear Models | 1 | 2017 | 854 | 0.030 |
Why?
| Phenotype | 1 | 2022 | 3070 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2016 | 884 | 0.030 |
Why?
| Vaccination | 1 | 2021 | 1241 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2021 | 2977 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3296 | 0.030 |
Why?
| Sex Factors | 1 | 2018 | 1860 | 0.030 |
Why?
| Communication | 1 | 2018 | 776 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2010 | 1519 | 0.030 |
Why?
| Health Promotion | 1 | 2008 | 707 | 0.030 |
Why?
| Biomarkers | 1 | 2022 | 3662 | 0.020 |
Why?
| Inflammation | 1 | 2022 | 2598 | 0.020 |
Why?
| Registries | 1 | 2018 | 2020 | 0.020 |
Why?
| Obesity | 1 | 2023 | 2786 | 0.020 |
Why?
| Veterans | 1 | 2009 | 1203 | 0.020 |
Why?
| Single-Blind Method | 1 | 2008 | 275 | 0.020 |
Why?
| Health Services Accessibility | 1 | 2009 | 813 | 0.010 |
Why?
|
|
Colborn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|